Identification of β-tubulin as a common immunogen in gastrointestinal malignancy by mass spectrometry of colorectal cancer proteome: Implications for early disease detection

Analytical and Bioanalytical Chemistry

Volumn 403, Issue 7, 2012, Pages 1801-1809

  Bouras, George ^a   Nakanishi, Toyofumi ^b   Fujita, Yoshihisa ^a   Tsunemi, Soichiro ^a   Takubo, Takayuki ^b   Tanigawa, Nobuhiko ^a  

^a Department of General and Gastrointestinal Surgery ^*  (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Biological samples; Biomedical analysis; Clinical; Genomics; Icp MS; Mass spectrometry; Proteomics

Indexed keywords

BIOLOGICAL SAMPLES; BIOMEDICAL ANALYSIS; CLINICAL; GENOMICS; ICP-MS; PROTEOMICS;

DISEASES; MASS SPECTROMETRY; MOLECULAR BIOLOGY; NITROCELLULOSE;

ANTIBODIES;

PROTEOME; TUBULIN; TUMOR MARKER; TUMOR PROTEIN;

COLORECTAL TUMOR; CONFERENCE PAPER; EARLY DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MASS SPECTROMETRY; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUBULIN; TUMOR MARKERS, BIOLOGICAL;

ARMORACIA RUSTICANA;

EID: 84864821865     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-5628-5     Document Type: Conference Paper

References (38)

1. Tan E, Gouvas N, Nicholls RJ, Ziprin P, Xynos E, Tekkis PP (2009) Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol 18(1):15-24
2. Albanopoulos K, Armakolas A, Konstadoulakis M, Leandros E, Tsiobanou E, Katsaragakis S, Alexious D, Androulakis G (2000) Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer. Am J Gastroenterol 95(4):1056-1061
3. Mintz PJ, Kim J, Do KA et al (2003) Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol 21:57-63
4. Lee AS (2007) GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 67(8):3496-3499
5. Scanlan M, Chen Y, Williamson B, Gure A, Stockert E, Gordan H, Tureci O, Sahin Y, Pfreundshuh M, Old L (1998) Characterization of human colon cancer antigen recognized by autologous antibodies. Int J Cancer 76:652-658
6. Fujita Y, Nakanishi T, Miyamoto Y, Hiramatsu M, Mabuchi H, Miyamoto A, Shimizu A, Takubo T, Tanigawa N (2008) Proteomics-based identification of autoantibody against heat hock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma. Cancer Lett 263:280-290
7. De Monte L, Sanvito F, Olivieri S, Vigano F, Doglioni C, Frason M, Braga M, Bachi A, Dellaona P, Pia Protti M, Alessio M (2008) Serological immunoreactivity against colon cancer proteome varies upon disease progression. J Prot Res 7:504-514
8. Nam M, Madoz-Gurpide J, Wang H, Lescure P, Schmalbach C, Zhao R, Misek D, Kuick R, Brenner D, Hanash S (2003) Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminalhydrolase L3. Proteomics 3:2108-211
9. Ran Y, Hu H, Zhou Z, Yu L, Sun L, Pan J, Liu J, Yang Z (2008) Profiling tumor-associated autoantibodies for the detection of colon cancer. Clin Cancer Res 14(9):2696-2700
10. Mou Z, He Y, Wu Y (2009) Immunoproteomics to identify tumorassociated antigens eliciting humoral response. Cancer Lett 278:123-129
11. Tanaka S, Sakai A, Kimura K, Yoshida H, Fushitani H, Ogata A, Miyamoto A, Fukushima M, Wada A, Tanigawa N (2008) Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis. Int J Oncol 33(2):361-370
12. Brichory F, Misek D, Yim A, Krause M, Giordano T, Beer D et al (2001) An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci USA 98:9824-9829
13. Kawasaki H, Toyoda H, Shinohara H, Okuda J, Watanae T, Yamamoto T et al (2001) Expression of surviving correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumoigenesis. Cancer 91:2026-2032
14. Nogales E (2000) Structural insites into microtubule function. Ann Rev Biochem 69:277-302
15. Sullivan KF (1998) Structure and utilization of tubulin isotypes. Ann Rev Cell Biol 4:687-716
16. Luduena RF (1998) Multiple forms of tubulin: different gene products and covalent modifications. Int Rev Cytol 178:207-275
17. Yeh IT, Luduena RF (2004) The βII isotype of tubulin is present in the cell nuclei of a variety of cancers. CellMotil Cytoskeleton 57:96-106
18. Jouhilahti EM, Peltonon S, Peltonen J (2008) Class III beta-tubulin is a component of the mitotic spindle in multiple cell types. J Histochem Cytochem 56(12):113-119
19. Desai A, Mitchison TJ (1997)Microtubule polymerization dynamics. Ann Rev Cell Dev Biol 13:83-117
20. Scott CA, Walker CC, Neal DA, Harper CE, Bloodgood RA, Somers KD, Mills SE, Rebhun LI, Levine PA (1990) Beta-tubulin epitope expression in normal and malignant epithelial cells. Arch Otolaryngol Head Neck Surg 116(5):583-589
21. Ferrandina G, Zannoni GF, Martinelli E, Praglia A, Gallotta V, Mozzetti S, Scambia G, Ferlini C (2006) Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients. Clin Cancer Res 12(9):2774-2779
22. Katsetos CD, Kontogeorgos G, Geddes JF, Herman MM, Tsimara-Papastamatious H, Yu Y, Sakkas LI, Tsokos M, Patchefsky AS, Ehya H, Cooper HS, Provencio J, Spano AJ, Frankfurter A (2000) Differential distribution of the neuron-associated class III betatubulin in neuroendocrine lung tumors. Arch Pathol Lab Med 124(4):535-544
23. Roh JY, Kee SH, Choi JW, Lee JH, Lee JH, Lee ES, Kim YS (2007) Expression of class II beta-tubulin in non-melanoma cutaneous tumors. J Cutan Pathol 34(2):166-173
24. Ranganathan S, Salazar H, Benetatos CA, Hudes GR (1997) Immunohistochemical analysis of beta-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy. Prostate 30(4):263-268
25. Jirasek T, Cipro S, Musilova A, Kubecova M, Mandys V (2009)Expression of class III ß-tubulin in colorectal carcinomas: an immunohistochemical study using TU-20 and TuJ-1 antibody. Indian J Med Res 129:89-94
26. Giarnieri E, De Francesco GP, Carico E, Midiri G, Amanti C, Giacomelli L, Tucci G, Gidaro S, Stroppa I, Gidaro G, Giovagnoli MR (2005) Alpha- and beta-tubulin in rectal cancer development. Anticancer Res 25(5):3237-3241
27. Hiser L, Aggarwal A, Young R, Frankfurter A, Spano A, Correia J, Lobert S (2006) Comparison of ß-tubulin mRNA and protein levels in 12 human cancer cell lines. Cell Motil Cytoskeleton 63:41-52
28. Gan P, Pasquier E, Kavallaris M (2007) Class III ß-tubulin mediates sensitivity to chemotherapeutic drugs in non-small cell lung cancer. Cancer Res 67(19):9356-9363
29. Kim JS, Lee YC, Nam HT, Li G, Yun EJ, Song KS, Seo KS, Park JH, Ahn JW, Zee OP, Park JI, Yoon WH, Lim K, Hwant BD (2007) Apicularen A induces cell death through Fas ligand up-regulation and microtubule disruption by tubulin down-regulation in HM7 human colon cancer cells. Clin Cancer Res 13(21):6509-6517
30. Jalbout M, Jrad B, Bouaouina N, Gargouri J, Yacoub S, Zakhama A, Khlifa R, Chouchane L (2002) Autoantibodies to tubulin are specifically associated with the young age onset of the nasopharyngeal carcinoma. Int J Cancer 101:146-150
31. Prasannan L, Misek D, Hinderer R, Michon J, Geiger J, Hanash S (2000) Identification of ß-tubulin isoforms as tumor antigens in neuroblastoma. Clin Cancer Res 6:3949-3956
32. Hamrita B, Chahed K, Kabbage M, Guillier C, Trimeche M, Chaieb A, Chouchane L (2008) Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA). Clin Chim Acta 393(2):95-102
33. Shukla S, Pranay A, D'Cruz AK, Chaturvedi P, Kane SV, Zingde SM (2009) Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response. Cancer Biomark 5(3):127-135
34. Svarcová J, Fialová L, Bartos A, Steinbachová M, Malbohan I (2008) Cerebrospinal fluid antibodies to tubulin are elevated in the patients with multiple sclerosis. Eur J Neurol 15(11):1173-1179
35. Bansal D, Herbert F, Lim P, Deshpande P, Bécavin C, Guiyedi V, de Maria I, Rousselle JC, Namane A, Jain R, Cazenave PA, Mishra GC, Ferlini C, Fesel C, Benecke A, Pied S (2009) IgG autoantibody to brain beta tubulin III associated with cytokine cluster-II discriminate cerebral malaria in Central India. PLoS One 4(12): e8245
36. Zou J, Yu XF, Bao ZJ, Dong J (2011) Proteome of human colon cancer stem cells: a comparative analysis. World J Gastroenterol 17(10):1276-1285
37. Juwana J, Henderikx P, Mischo A, Wadle A, Fadle N, Gerlach K, Arends J, Hoogenboom H, Pfreundschuh M, Renner C (1999) EB/ RP gene family encodes tubulin binding proteins. Int J Cancer 81 (2):275-284
38. s. Br J Cancer 80(8):1162-1168